Wed, 25 Sep 2024 14:31:25 GMT
Johnson and Johnson Q3
Johnson and Johnson (JNJ) Q1 and Q2 performance has been above market expected returns when it comes to Earnings performance. Although GAAP earnings and GAAP EPS for Q2 have been lower comparing to previous year (-12.8% and -5.9%), Q2 2024 Sales worldwide have increased by 4.3%.
Organic Growth and Free cash flow are key priorities of JNJ Capital Allocation strategy,